AKBOĞA, M. K. And Inanc, I. H. 2022. Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease. ANGIOLOGY , vol.73, no.3 , 281-282.

AKBOĞA, M. K., & Inanc, I. H., (2022). Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease. ANGIOLOGY , vol.73, no.3, 281-282.

AKBOĞA, MEHMET, And Ibrahim Halil Inanc. "Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease," ANGIOLOGY , vol.73, no.3, 281-282, 2022

AKBOĞA, MEHMET K. And Inanc, Ibrahim H. . "Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease." ANGIOLOGY , vol.73, no.3, pp.281-282, 2022

AKBOĞA, M. K. And Inanc, I. H. (2022) . "Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease." ANGIOLOGY , vol.73, no.3, pp.281-282.

@article{article, author={MEHMET KADRİ AKBOĞA And author={Ibrahim Halil Inanc}, title={Plasma Leukocyte Cell-Derived Chemotaxin 2 for the Severity of Coronary Artery Disease}, journal={ANGIOLOGY}, year=2022, pages={281-282} }